Efectos de la suspensión de IECA y ARAII en enfermedad crónica avanzada
Effects of suspending ACE inhibitors and ARBs in advanced chronic kidney disease
Leído
88206
Vecesse ha leído el artículo
5408
Total PDF
82798
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 219 | 18 | 237 |
| 2025 5 | 1228 | 87 | 1315 |
| 2025 4 | 1173 | 48 | 1221 |
| 2025 3 | 1269 | 72 | 1341 |
| 2025 2 | 1152 | 47 | 1199 |
| 2025 1 | 1037 | 51 | 1088 |
| 2024 12 | 910 | 47 | 957 |
| 2024 11 | 1293 | 79 | 1372 |
| 2024 10 | 1339 | 62 | 1401 |
| 2024 9 | 1158 | 51 | 1209 |
| 2024 8 | 1013 | 59 | 1072 |
| 2024 7 | 903 | 55 | 958 |
| 2024 6 | 749 | 54 | 803 |
| 2024 5 | 1023 | 66 | 1089 |
| 2024 4 | 927 | 62 | 989 |
| 2024 3 | 849 | 68 | 917 |
| 2024 2 | 841 | 53 | 894 |
| 2024 1 | 846 | 46 | 892 |
| 2023 12 | 746 | 50 | 796 |
| 2023 11 | 1092 | 65 | 1157 |
| 2023 10 | 1053 | 74 | 1127 |
| 2023 9 | 1007 | 58 | 1065 |
| 2023 8 | 1001 | 47 | 1048 |
| 2023 7 | 933 | 64 | 997 |
| 2023 6 | 1003 | 49 | 1052 |
| 2023 5 | 1318 | 63 | 1381 |
| 2023 4 | 884 | 57 | 941 |
| 2023 3 | 956 | 67 | 1023 |
| 2023 2 | 715 | 47 | 762 |
| 2022 1 | 624 | 49 | 673 |
| 2022 12 | 577 | 49 | 626 |
| 2022 11 | 950 | 71 | 1021 |
| 2022 10 | 832 | 81 | 913 |
| 2022 9 | 840 | 68 | 908 |
| 2022 8 | 789 | 83 | 872 |
| 2022 7 | 663 | 75 | 738 |
| 2022 6 | 676 | 82 | 758 |
| 2022 5 | 836 | 98 | 934 |
| 2022 4 | 663 | 80 | 743 |
| 2022 3 | 797 | 108 | 905 |
| 2022 2 | 674 | 108 | 782 |
| 2021 1 | 707 | 80 | 787 |
| 2021 12 | 585 | 64 | 649 |
| 2021 11 | 691 | 69 | 760 |
| 2021 10 | 702 | 90 | 792 |
| 2021 9 | 547 | 82 | 629 |
| 2021 8 | 506 | 59 | 565 |
| 2021 7 | 492 | 58 | 550 |
| 2021 6 | 559 | 83 | 642 |
| 2021 5 | 530 | 73 | 603 |
| 2021 4 | 890 | 189 | 1079 |
| 2021 3 | 686 | 85 | 771 |
| 2021 2 | 592 | 80 | 672 |
| 2020 1 | 381 | 63 | 444 |
| 2020 12 | 401 | 43 | 444 |
| 2020 11 | 443 | 52 | 495 |
| 2020 10 | 445 | 38 | 483 |
| 2020 9 | 514 | 28 | 542 |
| 2020 8 | 434 | 33 | 467 |
| 2020 7 | 412 | 29 | 441 |
| 2020 6 | 400 | 34 | 434 |
| 2020 5 | 501 | 51 | 552 |
| 2020 4 | 486 | 58 | 544 |
| 2020 3 | 518 | 53 | 571 |
| 2020 2 | 491 | 50 | 541 |
| 2020 1 | 447 | 47 | 494 |
| 2019 12 | 394 | 39 | 433 |
| 2019 11 | 608 | 52 | 660 |
| 2019 10 | 633 | 35 | 668 |
| 2019 9 | 853 | 59 | 912 |
| 2019 8 | 622 | 64 | 686 |
| 2019 7 | 602 | 68 | 670 |
| 2019 6 | 523 | 46 | 569 |
| 2019 5 | 708 | 87 | 795 |
| 2019 4 | 640 | 77 | 717 |
| 2019 3 | 528 | 61 | 589 |
| 2019 2 | 381 | 44 | 425 |
| 2019 1 | 328 | 38 | 366 |
| 2018 12 | 547 | 56 | 603 |
| 2018 11 | 790 | 19 | 809 |
| 2018 10 | 819 | 21 | 840 |
| 2018 9 | 1138 | 19 | 1157 |
| 2018 8 | 699 | 27 | 726 |
| 2018 7 | 520 | 25 | 545 |
| 2018 6 | 517 | 22 | 539 |
| 2018 5 | 617 | 22 | 639 |
| 2018 4 | 594 | 14 | 608 |
| 2018 3 | 492 | 12 | 504 |
| 2018 2 | 415 | 10 | 425 |
| 2018 1 | 422 | 9 | 431 |
| 2017 12 | 385 | 14 | 399 |
| 2017 11 | 529 | 11 | 540 |
| 2017 10 | 556 | 14 | 570 |
| 2017 9 | 504 | 14 | 518 |
| 2017 8 | 598 | 20 | 618 |
| 2017 7 | 506 | 16 | 522 |
| 2017 6 | 498 | 15 | 513 |
| 2017 5 | 536 | 15 | 551 |
| 2017 4 | 695 | 9 | 704 |
| 2017 3 | 640 | 8 | 648 |
| 2017 2 | 738 | 15 | 753 |
| 2016 1 | 331 | 6 | 337 |
| 2016 12 | 279 | 8 | 287 |
| 2016 11 | 402 | 15 | 417 |
| 2016 10 | 416 | 14 | 430 |
| 2016 9 | 621 | 28 | 649 |
| 2016 8 | 842 | 28 | 870 |
| 2016 7 | 487 | 23 | 510 |
| 2016 6 | 316 | 0 | 316 |
| 2016 5 | 243 | 0 | 243 |
| 2016 4 | 231 | 0 | 231 |
| 2016 3 | 215 | 0 | 215 |
| 2016 2 | 231 | 0 | 231 |
| 2015 1 | 212 | 0 | 212 |
| 2015 12 | 248 | 0 | 248 |
| 2015 11 | 189 | 0 | 189 |
| 2015 10 | 174 | 0 | 174 |
| 2015 9 | 195 | 0 | 195 |
| 2015 8 | 136 | 0 | 136 |
| 2015 7 | 192 | 0 | 192 |
| 2015 6 | 141 | 0 | 141 |
| 2015 5 | 256 | 0 | 256 |
| 2015 4 | 65 | 0 | 65 |
| 2015 2 | 4883 | 0 | 4883 |
Mostrar todo
